DEXBROMPHENIRAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Dexbrompheniramine patents expire, and what generic alternatives are available?
Dexbrompheniramine is a drug marketed by Avanthi Inc and is included in one NDA.
The generic ingredient in DEXBROMPHENIRAMINE is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEXBROMPHENIRAMINE?
- What are the global sales for DEXBROMPHENIRAMINE?
- What is Average Wholesale Price for DEXBROMPHENIRAMINE?
Summary for DEXBROMPHENIRAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | DEXBROMPHENIRAMINE at DailyMed |
US Patents and Regulatory Information for DEXBROMPHENIRAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avanthi Inc | DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE | dexbrompheniramine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 078648-001 | Feb 27, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
